Quantitative TOF monitoring for pediatrics
Safe and accurate neuromuscular blockade management for your most delicate patients
Safe and accurate neuromuscular blockade management for your most delicate patients
Studies indicate that children run an equally high risk of complications in the use of NMBAs as adults. That's why monitoring neuromuscular blockade is vital for enhancing the safety of of all patients, including your pediatric patients.
Knowing the current level of muscle paralysis will support you in making proactive and informed decisions.
Supporting you in your choice of neuromuscular blocking agents (NMBA).
Guiding you in choice of reversal agent type and reversal dose for your specific case.
Helping you to choose if spontaneous recovery is an option or not, and if adequate recovery of breathing muscles is obtained.
Assisting you in finding the correct timing for safe tracheal extubation.
Contact us to request a complimentary demo, and explore how TetraGraph and TetraSens Pediatric can help you enhance pediatric patient care.
TetraSens Pediatric can easily be placed on either hand or foot, helping to improve the workflow in your OR setting. It’s approved to be used on pediatric patients from 28 days after born.
Read this blog to learn four reasons why you should be using quantitative neuromuscular monitoring for pediatric patients.
Watch this roundtable discussion to hear a panel of experts sharing their experiences and insights on the challenges faced in pediatric anesthesia
Patient monitoring devices for monitoring neuromuscular blockade and respiratory function during and after surgery.
We're here to support you in elevating your practice. Start today by reading a blog, watching a video or a webinar.
A leading medical device company on a global mission to safeguard every patient's journey, from anesthesia to recovery.
We are on a mission to revolutionize perioperative care for 100 million patients globally.